H1N1 swine flu market in India is expected to see heightened action in the coming months as  more and more companies join the fray to launch own versions of the vaccine in the country.

A third wave of H1N1 swine flu infection surge is possible sometime this winter, alerts a section of flu experts.

South Korea no longer plans to buy GlaxoSmithKline Plc’s H1n1 swine flu vaccine, Pandemrix, reports said quoting health ministry officials.

A more dangerous strain of H1N1 swine flu virus is reportedly emerging.

Laninamivir, an inhaled drug to treat H1N1 swine flu, is also found effective against H5N1 avian influenza

Side-effect free No 2 Cold Medicine can cure children in a single dose, claims Chinese drug maker

Prodesse ProFlu-ST, a laboratory test kit to quickly diagnose 2009 H1N1 pandemic swine flu, granted emergency approval in US, its maker Gen-Probe Inc said in a new release.

Natco Pharma is another oseltamivir producer in race to launch syrup version for kids

Non-synthetic drug got permission to conduct human trials in US; awaits DCGI's approval to begin clinical studies in India

Vaccine makers see windfall sales as  H1N1 swine flu pandemic looms large